373 related articles for article (PubMed ID: 29583150)
1. Rheumatoid arthritis and risk of cardiovascular disease.
Meyer PW; Anderson R; Ker JA; Ally MT
Cardiovasc J Afr; 2018 Sep/Oct 23; 29(5):317-321. PubMed ID: 29583150
[TBL] [Abstract][Full Text] [Related]
2. [Rheumatoid arthritis and cardiovascular complications].
Seidel W; Hecker M; Wagner U; Häntzschel H
Z Rheumatol; 2006 Oct; 65(6):482, 484-6. PubMed ID: 16991011
[TBL] [Abstract][Full Text] [Related]
3. The management of cardiovascular disease risk in patients with rheumatoid arthritis.
Ahmed O; Krishnamurthy V; Kaba RA; Tahir H
Expert Opin Pharmacother; 2022 Jun; 23(8):947-958. PubMed ID: 35575484
[TBL] [Abstract][Full Text] [Related]
4. Cardiovascular disease and rheumatoid arthritis: an update.
Charles-Schoeman C
Curr Rheumatol Rep; 2012 Oct; 14(5):455-62. PubMed ID: 22791398
[TBL] [Abstract][Full Text] [Related]
5. [Cardiovascular comorbidity and its risk factors in rheumatoid arthritis].
Kleinert S; Krueger K
Z Rheumatol; 2011 Aug; 70(6):464-72. PubMed ID: 21863467
[TBL] [Abstract][Full Text] [Related]
6. Disease factors in early rheumatoid arthritis are associated with differential risks for cardiovascular events and mortality depending on age at onset: a 10-year observational cohort study.
Ajeganova S; Andersson ML; Frostegård J; Hafström I
J Rheumatol; 2013 Dec; 40(12):1958-66. PubMed ID: 23950188
[TBL] [Abstract][Full Text] [Related]
7. Cardiovascular disease in rheumatoid arthritis: medications and risk factors in China.
Li C; Wang XR; Ji HJ; Zhang XY; Li XF; Wang LZ; Wang CH; Wang YF; Yang R; Wang GC; Lu X; Zhu P; Chen LN; Jin HT; Liu JT; Liu XY; Sun L; Chen HY; Wei P; Wang JX; Cui LF; Shu R; Liu BL; Zhang ZL; Li GT; Li ZB; Yang J; Li JF; Jia B; Zhang FX; Tao JM; Han SL; Lin JY; Wei MQ; Liu XM; Ke D; Hu SX; Ye C; Yang XY; Li H; Huang CB; Gao M; Lai B; Li XF; Song LJ; Wang Y; Wang XY; Tang YD; Su Y; Mu R; Li ZG
Clin Rheumatol; 2017 May; 36(5):1023-1029. PubMed ID: 28342151
[TBL] [Abstract][Full Text] [Related]
8. Co-morbidities in established rheumatoid arthritis.
Gullick NJ; Scott DL
Best Pract Res Clin Rheumatol; 2011 Aug; 25(4):469-83. PubMed ID: 22137918
[TBL] [Abstract][Full Text] [Related]
9. Cardiovascular Risk in Rheumatoid Arthritis and Mechanistic Links: From Pathophysiology to Treatment.
Fragoulis GE; Panayotidis I; Nikiphorou E
Curr Vasc Pharmacol; 2020; 18(5):431-446. PubMed ID: 31258091
[TBL] [Abstract][Full Text] [Related]
10. Cause-Specific Mortality in Male US Veterans With Rheumatoid Arthritis.
England BR; Sayles H; Michaud K; Caplan L; Davis LA; Cannon GW; Sauer BC; Solow EB; Reimold AM; Kerr GS; Schwab P; Baker JF; Mikuls TR
Arthritis Care Res (Hoboken); 2016 Jan; 68(1):36-45. PubMed ID: 26097231
[TBL] [Abstract][Full Text] [Related]
11. Cardiovascular events in early RA are a result of inflammatory burden and traditional risk factors: a five year prospective study.
Innala L; Möller B; Ljung L; Magnusson S; Smedby T; Södergren A; Öhman ML; Rantapää-Dahlqvist S; Wållberg-Jonsson S
Arthritis Res Ther; 2011 Aug; 13(4):R131. PubMed ID: 21843325
[TBL] [Abstract][Full Text] [Related]
12. Rheumatoid arthritis-specific cardiovascular risk scores are not superior to general risk scores: a validation analysis of patients from seven countries.
Crowson CS; Gabriel SE; Semb AG; van Riel PLCM; Karpouzas G; Dessein PH; Hitchon C; Pascual-Ramos V; Kitas GD;
Rheumatology (Oxford); 2017 Jul; 56(7):1102-1110. PubMed ID: 28339992
[TBL] [Abstract][Full Text] [Related]
13. Safe use of antirheumatic agents in patients with comorbidities.
Makol A; Wright K; Matteson EL
Rheum Dis Clin North Am; 2012 Nov; 38(4):771-93. PubMed ID: 23137582
[TBL] [Abstract][Full Text] [Related]
14. Cardiovascular co-morbidity in early rheumatoid arthritis.
John H; Kitas G; Toms T; Goodson N
Best Pract Res Clin Rheumatol; 2009 Feb; 23(1):71-82. PubMed ID: 19233047
[TBL] [Abstract][Full Text] [Related]
15. Rheumatoid arthritis and cardiovascular disease: an update on treatment issues.
Barbhaiya M; Solomon DH
Curr Opin Rheumatol; 2013 May; 25(3):317-24. PubMed ID: 23466960
[TBL] [Abstract][Full Text] [Related]
16. Cardiovascular risk in rheumatoid arthritis.
Soubrier M; Barber Chamoux N; Tatar Z; Couderc M; Dubost JJ; Mathieu S
Joint Bone Spine; 2014 Jul; 81(4):298-302. PubMed ID: 24880190
[TBL] [Abstract][Full Text] [Related]
17. Disease-modifying antirheumatic drugs are associated with a reduced risk for cardiovascular disease in patients with rheumatoid arthritis: a case control study.
van Halm VP; Nurmohamed MT; Twisk JW; Dijkmans BA; Voskuyl AE
Arthritis Res Ther; 2006; 8(5):R151. PubMed ID: 16984661
[TBL] [Abstract][Full Text] [Related]
18. No increased cardiovascular mortality among early rheumatoid arthritis patients: a nationwide register study in 2000-2008.
Kerola AM; Nieminen TV; Virta LJ; Kautiainen H; Kerola T; Pohjolainen T; Kauppi MJ; Puolakka K
Clin Exp Rheumatol; 2015; 33(3):391-8. PubMed ID: 25936374
[TBL] [Abstract][Full Text] [Related]
19. Cardiovascular Risk Assessment and Therapeutic Implications in Rheumatoid Arthritis.
Halacoglu J; Shea LA
J Cardiovasc Transl Res; 2020 Oct; 13(5):878-890. PubMed ID: 32080804
[TBL] [Abstract][Full Text] [Related]
20. Cardiovascular outcomes of patients with rheumatoid arthritis prescribed disease modifying anti-rheumatic drugs: a review.
Giollo A; Bissell LA; Buch MH
Expert Opin Drug Saf; 2018 Jul; 17(7):697-708. PubMed ID: 29871535
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]